National Health Investors, Inc. (NYSE:NHI) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of National Health Investors, Inc. (NYSE:NHI) have been given an average rating of “Moderate Buy” by the seven research firms that are presently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $85.5714.

NHI has been the topic of several recent analyst reports. Wells Fargo & Company lifted their price objective on shares of National Health Investors from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 25th. Deutsche Bank Aktiengesellschaft cut shares of National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price target on the stock. in a research note on Tuesday, January 20th. Weiss Ratings reissued a “buy (b)” rating on shares of National Health Investors in a report on Monday, December 29th. National Bankshares set a $85.00 target price on National Health Investors in a report on Tuesday, January 20th. Finally, Truist Financial boosted their target price on National Health Investors from $81.00 to $83.00 and gave the stock a “buy” rating in a research report on Monday, December 15th.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of NHI. NewEdge Advisors LLC raised its stake in National Health Investors by 28.7% during the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after purchasing an additional 345 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of National Health Investors by 9.6% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust’s stock worth $18,460,000 after buying an additional 21,851 shares during the last quarter. Jane Street Group LLC raised its position in shares of National Health Investors by 1,728.4% during the 1st quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust’s stock valued at $5,148,000 after buying an additional 65,885 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of National Health Investors by 11.0% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 4,009 shares of the real estate investment trust’s stock valued at $284,000 after acquiring an additional 398 shares during the last quarter. Finally, Public Employees Retirement System of Ohio grew its position in National Health Investors by 4.1% in the second quarter. Public Employees Retirement System of Ohio now owns 66,931 shares of the real estate investment trust’s stock worth $4,693,000 after acquiring an additional 2,656 shares in the last quarter. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Stock Performance

NYSE NHI opened at $79.47 on Monday. The company has a quick ratio of 10.64, a current ratio of 10.64 and a debt-to-equity ratio of 0.74. National Health Investors has a twelve month low of $65.22 and a twelve month high of $81.48. The business has a 50-day moving average price of $78.11 and a 200-day moving average price of $76.37. The firm has a market cap of $3.79 billion, a price-to-earnings ratio of 25.07, a price-to-earnings-growth ratio of 2.72 and a beta of 0.67.

National Health Investors (NYSE:NHI) last issued its earnings results on Thursday, November 6th. The real estate investment trust reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.08. National Health Investors had a return on equity of 10.17% and a net margin of 41.38%.The company had revenue of $83.36 million for the quarter, compared to the consensus estimate of $85.66 million. During the same quarter last year, the company earned $1.03 EPS. The firm’s quarterly revenue was down 1.8% on a year-over-year basis. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. As a group, equities research analysts predict that National Health Investors will post 4.41 EPS for the current fiscal year.

National Health Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be issued a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 4.6%. The ex-dividend date of this dividend is Wednesday, December 31st. National Health Investors’s dividend payout ratio is 116.09%.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.